1-(2,3,5,6,7,8-hexahydroisoquinolin-3-yl)guanidine

ID: ALA4764564

PubChem CID: 162660810

Max Phase: Preclinical

Molecular Formula: C10H16N4

Molecular Weight: 192.27

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N=C(N)NC1C=C2CCCCC2=CN1

Standard InChI:  InChI=1S/C10H16N4/c11-10(12)14-9-5-7-3-1-2-4-8(7)6-13-9/h5-6,9,13H,1-4H2,(H4,11,12,14)

Standard InChI Key:  CDQCFGYTKJPHKT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 14 15  0  0  0  0  0  0  0  0999 V2000
   14.8752   -7.4831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5847   -7.0609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7317   -7.4655    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5776   -6.2330    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2998   -7.4698    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8611   -5.8275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0161   -7.0550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0128   -6.2265    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1542   -7.0731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1505   -6.2460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4364   -5.8379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7213   -6.2523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7250   -7.0794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4437   -7.4920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  9  1  2  0
  6 10  2  0
  7  8  2  0
  5  7  1  0
  2  5  1  0
  4  6  1  0
  7  3  1  0
  2  1  1  0
  2  4  1  0
  9 10  1  0
  9 14  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4764564

    ---

Associated Targets(Human)

ADRA2A Tclin Adrenergic receptor alpha-2 (812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 192.27Molecular Weight (Monoisotopic): 192.1375AlogP: 0.78#Rotatable Bonds: 1
Polar Surface Area: 73.93Molecular Species: BASEHBA: 2HBD: 4
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.57CX LogP: 0.57CX LogD: -1.84
Aromatic Rings: Heavy Atoms: 14QED Weighted: 0.37Np Likeness Score: 0.48

References

1. McMullan M,Kelly B,Mihigo HB,Keogh AP,Rodriguez F,Brocos-Mosquera I,García-Bea A,Miranda-Azpiazu P,Callado LF,Rozas I.  (2021)  Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity.,  209  [PMID:33139112] [10.1016/j.ejmech.2020.112947]

Source